Ledger.Open graph →
SEC Form D · filed March 29, 2024

Elicio Therapeutics, Inc

Offering
$6.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (33)

Brian Piekos · Boston, MAExecJay Venkatesan · Boston, MADirectorChristopher Haqq · Boston, MAExecJulian Adams · Boston, MADirectorPeter Demuth · Boston, MAExecYekaterina Chudnovsky · Boston, MADirectorAllen Nissenson · Boston, MADirectorRobert Ruffolo · Boston, MADirectorCarol Ashe · Boston, MADirectorKaren Wilson · Boston, MADirectorRobert Connelly · Boston, MAExec · DirectorAllen Nissenson · Boston, MADirectorJay Venkatesan · Boston, MADirectorRobert Connelly · Boston, MAExec · DirectorPeter Demuth · Boston, MAExecChristopher Haqq · Boston, MAExecRobert Ruffolo · Boston, MADirectorJulian Adams · Boston, MADirectorKaren Wilson · Boston, MADirectorBrian Piekos · Boston, MAExecYekaterina Chudnovsky · Boston, MADirectorCarol Ashe · Boston, MADirectorMatthew Maletta · Malvern, PADirectorJohn S. Gault · Austin, TXDirectorPaul Haycock · Dublin, IrelandExecDarin Bifani · Dublin, IrelandDirectorJuan Linietsky · Dublin, IrelandDirectorMatthew Koester · Madison, WIExecThomas Shivers · Dover, DEExec · DirectorBarret Ayres · Dover, DEDirectorShelly Kurtz · Omaha, NEDirectorBen Jackson · Omaha, NEExecDusty Davidson · Omaha, NEDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗